Evaluating the Likelihood to be Helped or Harmed after Treatment with Viloxazine Extended‐Release in Children and Adolescents with Attention Deficit/Hyperactivity Disorder

International Journal of Clinical Practice ◽

10.1111/ijcp.14330 ◽

2021 ◽

Author(s):

Azmi Nasser ◽

Alisa R. Kosheleff ◽

Joseph T. Hull ◽

Tesfaye Liranso ◽

Peibing Qin ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior stimulant treatment

10.26226/morressier.5785edd1d462b80296c9a2a5 ◽

2016 ◽

Author(s):

Jiri Prochazka

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Treatment ◽

Hyperactivity Disorder

Download Full-text

PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents

Value in Health ◽

10.1016/j.jval.2011.08.927 ◽

2011 ◽

Vol 14 (7) ◽

pp. A401-A402 ◽

Author(s):

V. Sikirica ◽

M. Erder ◽

J. Xie ◽

D. Macaulay ◽

M. Diener ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Children And Adolescents ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology

CNS Drugs ◽

10.1007/s40263-013-0102-x ◽

2013 ◽

Vol 27 (11) ◽

pp. 943-953 ◽

Author(s):

Vanja Sikirica ◽

Robert L. Findling ◽

James Signorovitch ◽

M. Haim Erder ◽

Ryan Dammerman ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Indirect Comparison ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

Adjusted Indirect Comparison

Download Full-text

Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents

Drugs of Today ◽

10.1358/dot.2010.46.5.1450095 ◽

2010 ◽

Vol 46 (5) ◽

pp. 299 ◽

Author(s):

D.F. Connor ◽

J. Rubin

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

Effect of methylphenidate formulation on attention deficit hyperactivity disorder (ADHD)-patients' adherence to medical treatment. A comparison of Medikinet retard® (extended-release [ER]) once daily and Medikinet® (immediate-release [IR]) twice daily in children and adolescents diagnosed with ADHD

http://isrctn.org/> ◽

10.1186/isrctn93724387 ◽

2012 ◽

Author(s):

Claudia Wachtarz

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Medical Treatment ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Immediate Release ◽

Hyperactivity Disorder

Download Full-text

Cost-effectiveness of guanfacine extended-release versus atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder in Canada

Value in Health ◽

10.1016/j.jval.2014.03.1250 ◽

2014 ◽

Vol 17 (3) ◽

pp. A213-A214

Author(s):

J. Lachaine ◽

V. Sikirica ◽

K. Mathurin

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents

PharmacoEconomics ◽

10.2165/11632920-000000000-00000 ◽

2012 ◽

Vol 30 (8) ◽

pp. e1-e15 ◽

Author(s):

Vanja Sikirica ◽

M. Haim Erder ◽

Jipan Xie ◽

Dendy Macaulay ◽

Melissa Diener ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cost Effectiveness ◽

Children And Adolescents ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Extended Release ◽

Hyperactivity Disorder

Download Full-text

PMH43 Treatment Patterns, Resource Utilization and Costs Associated with Guanfacine Immediate Release Versus Guanfacine Extended Release among Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD)

Value in Health ◽

10.1016/j.jval.2012.03.488 ◽

2012 ◽

Vol 15 (4) ◽

pp. A89

Author(s):

J. DiBello ◽

V. Sikirica ◽

T. Samuelson ◽

J. Xie ◽

T. He ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Resource Utilization ◽

Attention Deficit ◽

Extended Release ◽

Immediate Release ◽

Treatment Patterns ◽

Hyperactivity Disorder

Download Full-text

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior stimulant treatment

European Neuropsychopharmacology ◽

10.1016/s0924-977x(16)31891-0 ◽

2016 ◽

Vol 26 ◽

pp. S737

Author(s):

M. Huss ◽

A. Hervas ◽

B. Dirks ◽

C. Bliss ◽

J. Prochazka ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Stimulant Treatment ◽

Hyperactivity Disorder

Download Full-text

Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study

CNS Drugs ◽

10.1007/s40263-015-0241-3 ◽

2015 ◽

Vol 29 (4) ◽

pp. 331-340 ◽

Author(s):

Sharon B. Wigal ◽

Earl Nordbrock ◽

Akwete L. Adjei ◽

Ann Childress ◽

Robert J. Kupper ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Extended Release ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Hyperactivity Disorder

Download Full-text